[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016]

Wien Klin Wochenschr. 2016 Apr:128 Suppl 2:S62-7. doi: 10.1007/s00508-015-0924-2.
[Article in German]

Abstract

Blood pressure lowering is one of the most important interventions for reducing the vascular complications and mortality in patients with diabetes mellitus. Recent studies indicate that the optimal blood pressure level might be in the range between 130-140 mmHg systolic and 80‒90 mmHg diastolic. Lower blood pressure levels (e.g. 120/80 mmHg) can further reduce the risk for stroke and diabetic nephropathy, but are associated with increased cardiovascular mortality. In particular, very low blood pressure levels (< 120 mmHg) should be avoided in patients with coronary heart disease or peripheral arterial disease. Most patients with diabetes mellitus need antihypertensive combination therapies, whereby ACE-inhibitors or Angiotensin-II receptor antagonists should be first line drugs.

Keywords: Antihypertensive therapy; Blood pressure lowering; Diabetes mellitus; Diabetic nephropathy; Myocardial infarction; Peripheral arterial disease; Stroke.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Austria
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / prevention & control
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / prevention & control
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Evidence-Based Medicine
  • Humans
  • Hypertension / drug therapy
  • Hypertension / prevention & control*
  • Practice Guidelines as Topic*
  • Treatment Outcome

Substances

  • Antihypertensive Agents